Tried and tested: The psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study

Multiple Sclerosis

Volumn 15, Issue 1, 2009, Pages 75-80

  Gray, O M ^a   McDonnell, G V ^a   Hawkins, S A ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Multiple sclerosis; Multiple sclerosis impact scale (MSIS 29); Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERNAL CONSISTENCY; IRELAND; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPACT SCALE; POPULATION RESEARCH; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SELF REPORT; VALIDITY;

ADULT; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORTHERN IRELAND; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 58149083886     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508096872     Document Type: Article

References (20)

1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
2. Sharrack B Hughes RA Soudain S Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122: 141-159.
3. Hobart J Freeman J Thompson A. Kurtzke scales revisited: The application of psychometric methods to clinical intuition. Brain 2000; 123: 1027-1040.
4. Amato MP Ponziani G. Quantification of impairment in MS: Discussion of the scales in use. Mult Scler 1999; 5: 216-219.
5. Noseworthy JH Vandervoort MK Wong CJ Ebers GC. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 1990; 40: 971-975.
6. Ware JE Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
7. Vickrey BG Hays RD Harooni R Myers LW Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.
8. Cella DF Dineen K Arnason B. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129-139.
9. LaRocca NG Ritivo PG Miller DM Fischer JS Andrews H Paty DW. "Quality of life" assessment in multiple sclerosis clinical trials: Current status and strategies for improving multiple sclerosis clinical trial design. In: DE Goodkin RA Rudick, (eds), Multiple sclerosis: Advances in clinical trial design, treatment and future perpectives. London: Springer-Verlag; 1996. p. 145-160.
10. Pfennings LE Van der Ploeg HM Cohen L. A health-related quality of life questionnaire for multiple sclerosis patients. Acta Neurol Scand 1999; 100: 148-155.
11. Hobart J Lamping D Fitzpatrick R Riazi A Thompson A. The multiple sclerosis impact scale (MSIS-29): A new patient-based outcome measure. Brain 2001; 124: 962-973.
12. Riazi A Hobart JC Lamping DL Fitzpatrick R Thompson AJ. Evidence-based measurement in multiple sclerosis: The psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 2003; 9: 411-419.
13. Hoogervorst EL Zwemmer JN Jelles B Polman CH Uitdehaag BM. Multiple sclerosis impact scale (MSIS-29): Relation to established measures of impairment and disability. Mult Scler 2004; 10: 569-574.
14. McGuigan C Hutchinson M. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry 2004; 75: 266-269.
15. Hobart JC Riazi A Lamping DL Fitzpatrick R Thompson AJ. How responsive is the multiple sclerosis impact scale (MSIS-29)? A comparison with some other elf reported scales. J Neurol Neurosurg Psychiatry 2005; 76: 1539-1543.
16. Gray OM McDonnell GV Hawkins SA. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland. Mult Scler 2008; 14: 880-886.
17. Poser CM Paty DW Scheinberg L. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
18. McDonald WI Compston A Edan G. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
19. McHorney CA Ware JE. Construction and validation of an alternate form general mental health scale for the Medical Outcomes Study Short-Form 36-Item Health Survey. Med Care 1995; 33: 15-28.
20. Costelloe L O'Rourke K Kearney H. The patient knows best: Significant change in the physical component of the multiple sclerosis impact scale (MSIS-29 physical). J Neurol Neurosurg Psychiatry 2007; 78: 841-844.